Cargando…

Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease, and the currently available techniques for its detection are either invasive or less sensitive. To overcome this limitation, we present here a multiplexed point-of-care test that combines systemic inflammatory respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Digiacomo, Luca, Quagliarini, Erica, Pozzi, Daniela, Coppola, Roberto, Caracciolo, Giulio, Caputo, Damiano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251844/ https://www.ncbi.nlm.nih.gov/pubmed/37296945 http://dx.doi.org/10.3390/cancers15112983

Ejemplares similares

Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins
por: Caputo, Damiano, et al.
Publicado: (2022)

Magnetic Levitation of Personalized Nanoparticle–Protein Corona as an Effective Tool for Cancer Detection
por: Quagliarini, Erica, et al.
Publicado: (2022)

Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles
por: Digiacomo, Luca, et al.
Publicado: (2021)

Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer
por: Caputo, Damiano, et al.
Publicado: (2020)

Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection
por: Caputo, Damiano, et al.
Publicado: (2022)

Personalized Graphene Oxide-Protein Corona in the Human Plasma of Pancreatic Cancer Patients
por: Di Santo, Riccardo, et al.
Publicado: (2020)

Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection
por: Caputo, Damiano, et al.
Publicado: (2023)

Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
por: Palchetti, Sara, et al.
Publicado: (2019)

Nanotechnology and pancreatic cancer management: State of the art and further perspectives
por: Caputo, Damiano, et al.
Publicado: (2021)

Inhibiting the Growth of 3D Brain Cancer Models with Bio-Coronated Liposomal Temozolomide
por: Perini, Giordano, et al.
Publicado: (2021)

The influence of protein corona on Graphene Oxide: implications for biomedical theranostics
por: Quagliarini, Erica, et al.
Publicado: (2023)

The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells
por: Cui, Lishan, et al.
Publicado: (2022)

Mechanistic Insights into the Release of Doxorubicin from Graphene Oxide in Cancer Cells
por: Quagliarini, Erica, et al.
Publicado: (2020)

Magnetic Levitation Patterns of Microfluidic-Generated Nanoparticle–Protein Complexes
por: Digiacomo, Luca, et al.
Publicado: (2022)

Efficient Delivery of DNA Using Lipid Nanoparticles
por: Cui, Lishan, et al.
Publicado: (2022)

Effect of Protein Corona on The Transfection Efficiency of Lipid-Coated Graphene Oxide-Based Cell Transfection Reagents
por: Quagliarini, Erica, et al.
Publicado: (2020)

Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
por: Quagliarini, Erica, et al.
Publicado: (2021)

The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery
por: Cardarelli, Francesco, et al.
Publicado: (2016)

Effect of molecular crowding on the biological identity of liposomes: an overlooked factor at the bio-nano interface
por: Digiacomo, Luca, et al.
Publicado: (2019)

Interplay of protein corona and immune cells controls blood residency of liposomes
por: Giulimondi, Francesca, et al.
Publicado: (2019)

Role of Neoplastic Markers in Pancreatic Adenocarcinoma
por: Coppola, Alessandro, et al.
Publicado: (2022)

Author Correction: Interplay of protein corona and immune cells controls blood residency of liposomes
por: Giulimondi, Francesca, et al.
Publicado: (2020)

Optimal centrifugal isolating of liposome–protein complexes from human plasma
por: Digiacomo, Luca, et al.
Publicado: (2021)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

New Frontiers of Early Diagnosis of Pancreatic Fistula after Pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2022)

Principles for optimization and validation of mRNA lipid nanoparticle vaccines against COVID-19 using 3D bioprinting
por: Papi, Massimiliano, et al.
Publicado: (2022)

The Transformative Potential of Lipid Nanoparticle–Protein Corona for Next-Generation Vaccines and Therapeutics
por: Amici, Augusto, et al.
Publicado: (2023)

Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
por: Coppola, Alessandro, et al.
Publicado: (2023)

Preoperative systemic inflammatory biomarkers and postoperative day 1 drain amylase value predict grade C pancreatic fistula after pancreaticoduodenectomy
por: Caputo, Damiano, et al.
Publicado: (2020)

Time-lapse confocal imaging datasets to assess structural and dynamic properties of subcellular nanostructures
por: Ferri, Gianmarco, et al.
Publicado: (2018)

Can laboratory blood tests be used to risk stratify patients admitted with pneumonia?
por: Apps, L, et al.
Publicado: (2014)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Dynamic fingerprinting of sub-cellular nanostructures by image mean square displacement analysis
por: Digiacomo, Luca, et al.
Publicado: (2017)

Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments”
por: Coppola, Alessandro, et al.
Publicado: (2022)

Preoperative Computed Tomography to Predict and Stratify the Risk of Severe Pancreatic Fistula After Pancreatoduodenectomy
por: Sandini, Marta, et al.
Publicado: (2015)

Hot topics in pancreatic cancer management
por: Caputo, Damiano
Publicado: (2023)

Right hepatic artery anomalies in pancreatoduodenectomy—a risk for arterial resection but not for postoperative outcomes
por: La Vaccara, Vincenzo, et al.
Publicado: (2023)

CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis
por: Coppola, Alessandro, et al.
Publicado: (2021)

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019)

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hrbnph4kfhb1mfd9476vcon7f4